InFocus: ESG in healthcare – behaviour change, measurement and implementation
Reducing environmental impact and meeting social responsibility standards are now more important than ever to society. Junior associate Will Johnson and senior partner Adam...
Healthcare’s inflation-linked health check
The economic and geopolitical landscape changed dramatically early in 2022 with all parts of the economy, including healthcare and life sciences, left to face...
InSight: Is pharma doing enough on sustainability?
Neeshe Williams, general counsel and head of ESG at Pharmanovia, considers the issue of sustainability in the pharmaceutical industry. Pharmanovia is a UK-based international...
InSight: Mansfield Advisors assesses capacity investment opportunities in European APIs
Covid-19 has unveiled the fragility of supply chains in many sectors, and API production is no exception. Associate Abhishek Patel, and senior partners Adam...
InSight: Scope outlines its ESG considerations for credit ratings
Scope Ratings, the largest European credit rating agency, has outlined its ESG considerations for rating pharmaceutical companies. Olaf Tölke, head of corporate ratings, and...
InFocus: It’s not just a question of cost in Gx, according to Mansfield Advisors
Dr Victor Chua, senior partner, together with Indah Roesyanto and Dr Molly Llewellyn-Smith, associates at Mansfield Advisors, take a look at opportunities in generics,...
InSight: Healthcare Private Equity in Asia-Pacific – A multi-year growth trajectory
Vikram Kapur, leader of Bain’s APAC Healthcare practice, shares Asian insight from the firm’s Global Healthcare Private Equity and M&A report 2022
Bain & Company’s...
InFocus: LEK’s Adrienne Rivlin looks at the use of psychedelics in treating mental illness
Mental health issues are a rising global concern, with the World Health Organization (WHO) reporting a 13% increase in mental health conditions and substance...
InFocus: Verena Ahnert and Andre Valente, Partners at L.E.K. Consulting, analyse sustainability in the...
At the Glasgow Conference of Parties (COP26) in November 2021, governments and the private sector sought to put the global economy on the path...
Feature: Mansfield Advisors ask ‘Can investors make even more out of manufacturing for pharma?’
Associate Ali Bahram and senior partner Adam Scott of Mansfield Advisors take a close look at a growing and unconsolidated sector already strewn with...
Advertisement
